Literature DB >> 11012610

Serological markers of disease activity in tuberculosis and HIV infection.

A Marchant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11012610      PMCID： PMC1905751          DOI： 10.1046/j.1365-2249.2000.01371.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  35 in total

1.  'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.

Authors:  M M Lederman; L A Kalish; D Asmuth; E Fiebig; M Mileno; M P Busch
Journal:  AIDS       Date:  2000-05-26       Impact factor: 4.177

Review 2.  T cell life and death signalling via TNF-receptor family members.

Authors:  G Screaton; X N Xu
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

3.  Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy.

Authors:  J M Franco; A Rubio; C Rey; M Leal; J Macías; J A Pineda; B Sánchez; A Sánchez-Quijano; A Nuñez-Roldán; E Lissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-10       Impact factor: 3.267

4.  Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection.

Authors:  M H Godfried; T van der Poll; G J Weverling; J W Mulder; J Jansen; S J van Deventer; H P Sauerwein
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

5.  55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages.

Authors:  G Herbein; S Gordon
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.

Authors:  H Whittle; A Egboga; J Todd; T Corrah; A Wilkins; E Demba; G Morgan; M Rolfe; N Berry; R Tedder
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

7.  Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.

Authors:  M H Godfried; T van der Poll; J W Mulder; G J Weverling; E Endert; J M Lange; H P Sauerwein
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-12-15

8.  Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.

Authors:  R Zangerle; H Gallati; M Sarcletti; G Weiss; H Denz; H Wachter; D Fuchs
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-01

9.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

10.  Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells.

Authors:  D K Dalton; L Haynes; C Q Chu; S L Swain; S Wittmer
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307
View more
  1 in total

1.  Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.

Authors:  A De Milito; S Aleman; R Marenzi; A Sonnerborg; D Fuchs; M Zazzi; F Chiodi; Fuchs D
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.